Effectiveness of a One-day Psychoeducation Program on Internalized Stigmatization for BPD Patients (EDUC-BPD)

June 29, 2022 updated by: University Hospital, Montpellier

Effectiveness of a One-day Psychoeducation Program on Internalized Stigmatization for Borderline Personality Disorder (BPD) Patients

Education day on borderline personality disorder (BPD), including a transmission of current scientific knowledge on the disease. A dimensional understanding of BPD is delivered as well as disidentification of oneself to the symptoms of borderline personality disorder (Ducasse 2020 Eur Arch Psychiatry Clin Neurosci). The main objective is to evaluate the impact of borderline education day on self-stigma.

Study Overview

Detailed Description

Borderline personality disorder defined as "a pattern of instability in interpersonal relationships, self-image and affects, and impulsiveness marked" concerns 4-6% of the general population. This is the emotional trouble the most associated with the occurence of suicide attempts (85% of these patients make multiple suicide attempts) and death by suicide (10% of these patients). This is a major public health problem.

A large number of patients with borderline personality disorder are not informed of their diagnosis. The main reasons are : the non-recognition of this disorder by health professionals, the belief that borderline personality disorder is a overly stigmatizing diagnosis , or preference to diagnose another disorder - that professionals think respond better to treatments and therefore be of a better prognosis.

Patients with borderline personality disorder often think themselves as "bad people" or the only people suffering from these symptoms. Thus, the ignorance of borderline personality disorder by patients leads to a basis of their altered sense of identity, perceived as defective or isolated. This generate a strong internalized stigma.

Many people diagnosed with borderline personality disorder receive no information about this disorder while psychoeducation has shown its effectiveness in severe psychiatric disorders, including the disorder of borderline personality, by reducing the negative repercussions psychiatric pathology. Moreover, the education of patients suffering from self-stigma makes it possible to in the face of negative beliefs around the disease and the acquisition of knowledge about the disorder and how to deal with it reduces self-stigma in bipolar patients. However, the propensity to feel shame - the stigmatization of oneself as worthless - is strongest in borderline personality disorder compared to all psychiatric disorders and most associated with the occurence of suicidal behaviors. In recommendations with good clinical practice, the investigator propose within the sector a day of education on borderline personality disorder including a transmission of current scientific knowledge on the illness, a dimensional understanding of the disorder, and the dis-identification of self to the symptoms of borderline personality disorder. The investigator hypothesize that this day of psychoeducation makes it possible to decrease self-stigma, which could be a mediator in reducing negative repercussions of borderline pathology.

Study Type

Observational

Enrollment (Actual)

50

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Montpellier, France, 34000
        • University Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

The study population is patients with Borderline Personality disorder assesed according to the SCID II

Description

Inclusion Criteria:

  • Patients with Borderline Personality disorder assessed according to SCID II
  • Having attended the borderline education day

Exclusion Criteria:

  • None

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Retrospective

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Comparison of internalized stigma of mental illnessillness
Time Frame: At immediate post-intervention
Comparison of internalized stigma of mental illness between pre-treatment
At immediate post-intervention
Comparison of internalized stigma of mentalillness
Time Frame: At 3 months post-intervention
Comparison of internalized stigma of mental illness between pre-treatment
At 3 months post-intervention

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Depressive symptoms using the Beck Depression Inventory
Time Frame: At immediate post-intervention
Comparison of depressive symptoms between pre-treatment and post-intervention
At immediate post-intervention
Depressive symptoms using the Beck Depression Inventory
Time Frame: At 3 months post-intervention
Comparison of depressive symptoms between pre-treatment and 3 months post-intervention
At 3 months post-intervention
Severity of suicidal ideation evaluated by the likert scales from 0 (none) to 10 (maximum possible suicidal ideation)
Time Frame: At immediate post-intervention
Comparison of the intensity of suicidal ideation between pre-treatment and post-intervention
At immediate post-intervention
Severity of suicidal ideation evaluated by the likert scales from 0 (none) to 10 (maximum possible suicidal ideation)
Time Frame: At 3 months post-intervention
Comparison of the intensity of suicidal ideation between pre-treatment and 3 months post-intervention
At 3 months post-intervention
Psychological pain using the Likert scales from 0 (none) to 10 (maximum possible pain)
Time Frame: At immediate post-intervention
Comparison of psychological pain between pre-treatment and post-intervention
At immediate post-intervention
Psychological pain using the Likert scales from 0 (none) to 10 (maximum possible pain)
Time Frame: At 3 months post-intervention
Comparison of psychological pain between pre-treatment and 3 months post-intervention
At 3 months post-intervention
The intensity of hopelessness using the Likert scales from 0 (none) to 10 (maximum possible hopelessness)
Time Frame: At immediate post-intervention
Comparison of the intensity of hopelessness between pre-treatment and post-intervention
At immediate post-intervention
The intensity of hopelessness using the Likert scales from 0 (none) to 10 (maximum possible hopelessness)
Time Frame: At 3 months post-intervention
Comparison of the intensity of hopelessness between pre-treatment and 3 months post-intervention
At 3 months post-intervention
The intensity of optimism using analog visual scale
Time Frame: At immediate post-intervention
Comparison of the intensity of optimism between pre-treatment and post-intervention
At immediate post-intervention
The intensity of optimism using analog visual scale
Time Frame: At 3 months post-intervention
Comparison of the intensity of optimism between pre-treatment and 3 months post-intervention
At 3 months post-intervention
Feeling of pleasure using the quality of life questionnaire on pleasure and satisfaction
Time Frame: At immediate post-intervention
Comparison of feeling of pleasure between pre-treatment and post-intervention
At immediate post-intervention
Feeling of pleasure using the quality of life questionnaire on pleasure and satisfaction
Time Frame: At 3 months post-intervention
Comparison of feeling of pleasure between pre-treatment and 3 months post-intervention
At 3 months post-intervention
Feeling of satisfaction using the quality of life questionnaire on pleasure and satisfaction
Time Frame: At immediate post-intervention
Comparison of feeling of satisfaction between pre-treatment and post-intervention
At immediate post-intervention
Feeling of satisfaction using the quality of life questionnaire on pleasure and satisfaction
Time Frame: At 3 months post-intervention
Comparison of feeling of satisfaction between pre-treatment and 3 months post-intervention
At 3 months post-intervention
Anxiety state using the State-Trait Inventory (STAI-State)
Time Frame: At immediate post-intervention
Comparison of the state of anxiety between pre-treatment and post-intervention
At immediate post-intervention
Anxiety state using the State-Trait Inventory (STAI-State)
Time Frame: At 3 months post-intervention
Comparison of the state of anxiety between pre-treatment and 3 months post-intervention
At 3 months post-intervention
Hopelessness using the Beck Hopelessness Scale (BHS)
Time Frame: At immediate post-intervention
Comparison of the hopelessness between pre-treatment and post-intervention
At immediate post-intervention
Hopelessness using the Beck Hopelessness Scale (BHS)
Time Frame: At 3 months post-intervention
Comparison of the hopelessness between pre-treatment and 3 months post-intervention
At 3 months post-intervention
Level of positive and negative affects using the PANAS Scale
Time Frame: At immediate post-intervention
Comparison of level of positive and negative affects between pre-treatment and post-intervention
At immediate post-intervention
Level of positive and negative affects using the PANAS Scale
Time Frame: At 3 months post-intervention
Comparison of level of positive and negative affects between pre-treatment and 3 months post-intervention
At 3 months post-intervention

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 1, 2021

Primary Completion (Actual)

January 1, 2021

Study Completion (Actual)

September 1, 2021

Study Registration Dates

First Submitted

June 16, 2022

First Submitted That Met QC Criteria

June 16, 2022

First Posted (Actual)

June 23, 2022

Study Record Updates

Last Update Posted (Actual)

July 5, 2022

Last Update Submitted That Met QC Criteria

June 29, 2022

Last Verified

May 1, 2022

More Information

Terms related to this study

Other Study ID Numbers

  • RECHMPL21_0611

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

Undecided

IPD Plan Description

NC

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Borderline Personality Disorder

Clinical Trials on Psychoeducation day on borderline personality disorder

3
Subscribe